| 000 | 01648 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514072704.0 | ||
| 264 | 0 | _c20030805 | |
| 008 | 200308s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6600996 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAtzpodien, J | |
| 245 | 0 | 0 |
_aRapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcome. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cJul 2003 |
||
| 300 |
_a50-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Status |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aInterleukin-2 _xadverse effects |
| 650 | 0 | 4 |
_aIsotretinoin _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aOutpatients |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKüchler, Th | |
| 700 | 1 | _aWandert, T | |
| 700 | 1 | _aReitz, M | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 89 _gno. 1 _gp. 50-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6600996 _zAvailable from publisher's website |
| 999 |
_c12620668 _d12620668 |
||